Practice Updates for April/May: Breast and Labial Surgery in Adolescents, Zika and More


Stay up to date with ACOG's authoritative clinical guidance and helpful patient education materials. The following provides Practice Updates for April and May 2016.



Featured Committee Opinion: Breast and Labial Surgery in Adolescents

On April 21, 2016, the American College of Obstetricians and Gynecologists released a new Committee Opinion, "Breast and Labial Surgery in Adolescents," to aid members who are in a unique position to screen, counsel, and educate young patients about these topics. Female adolescents may be under particular stress to conform to societal conceptions of the "ideal" body. Increasingly, obstetrician-gynecologists are receiving requests from young women for advice about surgery for the breast or vulva to improve appearance and function.

When adolescents seek medical treatment, the first step is often education and reassurance regarding normal variation in anatomy, growth, and development. "There is a wide range of what is considered 'normal,'" stated Julie Strickland, MD, MPH the chair of ACOG's Adolescent Health Care Committee and lead author of the Committee Opinion. "It's important for ob-gyns to discuss sexual development and the variability of what breasts and genitalia may look like."

Committee Opinion #662, "Breast and Labial Surgery in Adolescents," is published in the May issue of Obstetrics & Gynecology.

Zika Updates: CDC Confirms that Prenatal Zika Virus Causes Microcephaly and Other Fetal Brain Anomalies

Scientists at the CDC have concluded, after careful review of existing evidence, that Zika virus is a cause of microcephaly and other severe fetal brain defects. In the report published in the New England Journal of Medicine on April 13, 2016-- Zika Virus and Birth Defects- Reviewing the Evidence for Causality--the CDC authors describe a rigorous weighing of evidence using established scientific criteria. Read the ACOG Statement on the CDC Update and Zika Virus.

Also, bookmark to stay up to date on the best and most relevant information on Zika specifically for ob-gyns and women’s health care providers. 

Featured Practice Bulletins Provide Revised Recommendations on Screening and Testing for Genetic Disorders

To meet the need of providing all women with accurate information to make appropriate decisions regarding the various forms of genetic screening and diagnostic testing available in pregnancy, ACOG and the Society for Maternal-Fetal Medicine (SMFM) released two Practice Bulletins: "Screening for Fetal Aneuploidy" and "Prenatal Diagnostic Testing for Genetic Disorders."

According to the revised Practice Bulletins, prenatal genetic screening is designed to assess whether a patient is at increased risk of having a fetus affected with a genetic disorder, such as fetal Down syndrome. In contrast, prenatal genetic diagnostic testing is intended to diagnose, with as much certainty as possible, whether a specific genetic disorder or condition is present in the fetus. Women with a positive screening result for fetal genetic disorders should always be offered further counseling and diagnostic testing. Prenatal genetic screening and diagnostic testing should be discussed as early as possible in pregnancy, ideally at the first obstetric visit, so that first trimester options are available.

Both Practice Bulletins were originally "published-ahead-of-print" in March 2016. 



New Committee Opinions

See all Committee Opinions

New Practice Bulletins (members only) 

See all Practice Bulletins

New Patient Education Pamphlets (members only)

See all Patient Education Pamphlets


New Frequently Asked Questions (FAQs) for Patients

  • 032 A Partner’s Guide to Pregnancy (May 2016)
  • 119 Exercise During Pregnancy (May 2016)
  • 182 Obesity and Pregnancy (April 2016)
  • 022 Barrier Methods of Birth Control (April 2016)

See all Frequently Asked Questions 

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998